News Conference News ESC 2020 New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials Caitlin E. Cox September 03, 2020
News Conference News SCCT 2020 For Cardiac CT, COVID-19 Has Toppled Silos and Paved the Way for Change Yael L. Maxwell July 28, 2020
News Daily News Multivessel PCI May Be Safe in Select Shock Patients With Impella Support Todd Neale April 29, 2020
News Daily News Takotsubo Snapshot Reveals Some Surprises: InterTAK Registry Yael L. Maxwell April 27, 2020
News Conference News CRT 2020 Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback Michael O'Riordan February 28, 2020
News Conference News STS 2020 PE for Surgeons: Be Active Participants in Team-Based Care, Experts Urge Yael L. Maxwell February 03, 2020
News Conference News AHA 2019 More Adverse Events, Higher Costs With Impella: New Observational Studies Caitlin E. Cox November 17, 2019
News Daily News For Percutaneous LVADs, Vascular Complications Decreasing but Still Common Caitlin E. Cox November 06, 2019
News Conference News TCT 2019 NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival Caitlin E. Cox October 10, 2019
News Conference News TCT 2019 In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock Caitlin E. Cox October 04, 2019
News Conference News TCT 2019 Strokes Increasing in STEMI Patients With Cardiogenic Shock Todd Neale September 25, 2019
News Daily News SCAI Shock Definition Tracks Well With Mortality in Cardiac ICU Todd Neale September 24, 2019
News Conference News EuroPCR 2019 Cardiogenic Shock Old and New: IABPs a Thing of the Past and ECMO Under Study Caitlin E. Cox June 05, 2019
News Conference News SCAI 2019 National Cardiogenic Shock Initiative Shows Potential to Increase Survival Yael L. Maxwell May 23, 2019
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Daily News Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany Caitlin E. Cox May 14, 2019
News Industry News FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy May 13, 2019